Helsinn

Home > Irish Pharmaceuticals > News > News 2005

06/12/2005	HELSINN PARTICIPATES IN THE SOCIETY FOR NEUROSCIENCE SATELLITE SYMPOSIUM: “The 5-HT3 Receptor: A model Cys-Loop Ligand-Gated Ion Channel”
28/11/2005	HELSINN SPONSORS THE 2nd EUROPEAN HEALTH FORUM, PARIS
22/11/2005	HELSINN RECEIVES THE ARMR RARE DISEASES AWARD
18/11/2005	HELSINN HEALTHCARE’S PARTICIPATION IN THE 13TH EDITION OF THE EUROPEAN CANCER CONFERENCE (ECCO), PARIS, FRANCE
16/11/2005	HELSINN's PARTICIPATION at CPhI Worldwide 2005
08/11/2005	HELSINN HEALTHCARE JOINS ROCHE ITALY IN ITS CELEBRATION MARKING AULIN’S 20th ANNIVERSARY
31/10/2005	HELSINN's Exhibition at CPhI Worldwide 2005
28/10/2005	HELSINN HEALTHCARE SA CELEBRATES NIMESULIDE’S 20th ANNIVERSARY
25/10/2005	ALOXI AT THE ECCO 2005 CONFERENCE
13/10/2005	Helsinn Birex Pharmaceuticals Ltd & Helsinn Chemicals Ireland Ltd win top honours at the annual NISO Occupational Safety Awards ceremony
08/10/2005	DRUGS: NIMISULIDE IS 20 YEARS OLD, AMONG THE TOP 5 ANTI-INFLAMMATORY DRUGS FARMACI: NIMESULIDE HA 20 ANNI,TRA I PRIMI 5 ANTINFIAMMATORI (ANSA)
06/09/2005	Helsinn Healthcare SA to present at the UBS 2005 Global Life Sciences Conference
14/07/2005	ALOXI AT THE MASCC 2005 CONGRESS
13/07/2005	HELSINN’S STRONG PRESENCE AT THE EULAR 2005 WITH ORIGINAL NIMESULIDE AND OXAPROZIN
16/06/2005	HELSINN AND ANGELINI ANNOUNCE A LICENSE AGREEMENT FOR ALOXI® IN PORTUGAL
10/06/2005	EXELIXIS AND HELSINN SIGN AGREEMENT FOR XL119 (BECATECARIN)
31/05/2005	Helsinn Healthcare Licenses a Supportive Care Product from Roche
25/05/2005	NIMESULIDE and OXAPROZIN at the EULAR 2005 Congress Vienna, 8-11 June
18/05/2005	HELSINN’S ISO 14001 and OHSAS 18001 CERTIFICATION
11/05/2005	Helsinn Birex Therapeutics Ltd. announces the launch of the new 5-HT3 Receptor Antagonist ALOXI® (Palonosetron hydrochloride) EU/1/04/306/001 in Ireland
02/05/2005	ALOXI® AT THE ASCO 2005 ANNUAL MEETING
21/04/2005	HELSINN AND PHARMASWISS ANNOUNCE A LICENSE AGREEMENT FOR ALOXI® IN BALTIC STATES, SLOVENIA AND SOME EASTERN EUROPEAN COUNTRIES
30/03/2005	HELSINN'S NEW ANTIEMETIC DRUG ALOXI® RECEIVES MARKETING AUTHORIZATION IN EUROPE
24/03/2005	HELSINN AND CSC ANNOUNCE A LICENSE AGREEMENT FOR ALOXI® IN CENTRAL AND EASTERN EUROPE
15/02/2005	HELSINN AND GALENICA ANNOUNCE A LICENSE AGREEMENT FOR ALOXI® (PALONOSETRON) IN GREECE
26/01/2005	HELSINN AND RIBOSEPHARM ANNOUNCE A LICENSE AGREEMENT FOR ALOXI® (PALONOSETRON) IN GERMANY
12/01/2005	HELSINN AND KALBE ANNOUNCE A LICENSE AGREEMENT FOR ALOXI® (PALONOSETRON) IN INDONESIA